Publication | Closed Access

Immunomodulatory and enhanced antitumor activity of a modified thymosin α1 in melanoma and lung cancer

Modified Thymosin α1Cancer ImmunosurveillanceEnhanced Antitumor ActivityImmunologyTumor ImmunityImmune SurveillanceImmune Checkpoint InhibitorImmunotherapeuticsAnti-cancer AgentImmunotherapyMedicineRadiation OncologyLung CancerCancer Research